| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.098 | 0.005 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.14 | 0.006 |